June 25, 2019 / 11:43 AM / 4 months ago

BUZZ-Bausch Health gains as co launches plaque psoriasis lotion

** U.S.-listed shares of Bausch Health Companies rise 3.5% to $24.60 in premarket trading

** Co launches Duobrii, its topical plaque psoriasis treatment, which is expected to be a key revenue driver

** Duobrii will be commercially available to healthcare professionals starting this week - Bausch

** Duobrii was approved in the United States in April and is part of Bausch’s “Significant Seven”, a suite of seven key products expected to generate more than $1 bln in sales over the next 5 years

** Up to Monday’s close, stock had risen 28.6% this year (Reporting by Tamara Mathias in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below